| SGLT2 inhibitors and mechanisms of hypertension A Briasoulis, O Al Dhaybi, GL Bakris Current cardiology reports 20, 1-7, 2018 | 86 | 2018 |
| Mineralocorticoid antagonists in chronic kidney disease O Al Dhaybi, G Bakris Current Opinion in Nephrology and Hypertension 26 (1), 50-55, 2017 | 30 | 2017 |
| Non‐steroidal mineralocorticoid antagonists: Prospects for renoprotection in diabetic kidney disease O Al Dhaybi, GL Bakris Diabetes, Obesity and Metabolism 22, 69-76, 2020 | 19 | 2020 |
| Renal targeted therapies of antihypertensive and cardiovascular drugs for patients with stages 3 through 5d kidney disease O Ai Dhaybi, GL Bakris Clinical Pharmacology & Therapeutics 102 (3), 450-458, 2017 | 11 | 2017 |
| Initial Single‐Pill Blood Pressure–Lowering Therapy: Should It Be for Most People? O Al Dhabyi, GL Bakris Journal of the American Heart Association 6 (11), e007760, 2017 | 3 | 2017 |
| New onset hypertension linked to generic cyclosporine substitution in post-renal transplant patient O Al Dhaybi, G Bakris American Journal of Nephrology 44 (3), 219-223, 2016 | 3 | 2016 |
| Hypertension and Chronic Kidney Disease Including Dialysis O Al Dhaybi, GL Bakris Hypertension, 393-404, 2024 | 1 | 2024 |
| Mineralocorticoid Receptor Antagonists—Evidence for Kidney Protection, Trials With Novel Agents O Al Dhaybi, GL Bakris Advances in Chronic Kidney Disease 28 (4), 371-377, 2021 | 1 | 2021 |
| Albuminuria is Your Guide to Assessing Future GFR Slope O Al Dhaybi, GL Bakris Kidney International Reports 9 (2), 194-196, 2024 | | 2024 |
| Blood Pressure Thresholds for Initiation of Drug Treatment: Blood Pressure Targets in Diabetes O Al Dhaybi, GL Bakris Blood Pressure Disorders in Diabetes Mellitus, 377-387, 2023 | | 2023 |
| Factitious acidosis and severe hypoalbuminemia caused by unsuspected assay interference O Al Dhaybi, GL Bakris Clinical Kidney Journal 14 (3), 1023-1024, 2021 | | 2021 |
| Blood pressure reduced to new guideline goals in patients with high‐normal glucose further reduces cardiovascular events O Al Dhaybi, GL Bakris The Journal of Clinical Hypertension 20 (4), 625, 2018 | | 2018 |
| 1198: A RARE CASE OF COMBINATION OF LANGERHANS CELL HISTIOCYTOSIS AND HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS S Gautam, O Dhaybi, N Maaty, M Seneff, D Davison Critical Care Medicine 43 (12), 301, 2015 | | 2015 |
| An Unusual Case of Fever of Unknown Origin O Al Dhaybi, P Bellamkonda Chest 144 (4), 235A, 2013 | | 2013 |
| Prostate cancer management: Racial disparities in the United States. O Al Dhaybi, PT Silberstein Journal of Clinical Oncology 31 (15_suppl), e16012-e16012, 2013 | | 2013 |
| Chronic kidney disease as independent risk factor for cardiovascular disease MD Omar Al Dhaybi, G Bakris | | |
